Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Proprietary Nano-Emulsion Technology for Rapid-Onset of Cannabinoid Effects

  • Organigram’s proprietary nano-emulsion technology is expected to provide an initial onset of effects within 10 to 15 minutes for cannabis beverages
  • The company’s shelf-stable, thermally stable, water-compatible and palatable cannabinoid nano-emulsion formulation allows for the production of both liquid and powdered beverage products
  • Organigram plans to launch dried powder formulation beverage products in early 2020

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), the parent company of leading licensed cannabis producer and cannabis-derived products manufacturer Organigram Inc., has developed a proprietary nano-emulsification technology. This new unique, fast-acting formulation will allow for the production of both powdered and liquid cannabinoid products. The development comes in the context of the much-anticipated legalization of adult recreational-use cannabis edibles in Canada and the ensuing boost in demand, as the company noted in a news release (

Organigram focuses on high-quality, indoor-grown cannabis for both medical patients and adult recreational users. Its proprietary technology allows for the development of products with a quick onset of the cannabinoid effect within 10 to 15 minutes. To determine the onset of the products, Organigram studied cannabinoid particles at a size of 20 nanometers. Organigram’s nano-emulsion technology is stable to temperature variations, mechanical disturbance, salinity, pH and sweeteners. Further testing is anticipated to occur in order to confirm the onset of action and the duration of the effect.

Previously, Organigram announced the launch of premium cannabinoid-infused chocolates. The company will also be working toward the release of additional dried powder formulation beverages in Canada in early 2020.

“This is an exciting time for cannabis product makers”, Organigram CEO Greg Engel said in a news release. “To ensure the satisfaction of adult consumers, companies have to deliver both predictability and reliability. Organigram’s technology and the powdered formulation put the customer in control, allowing them to infuse just about any beverage… This new method of delivery allows for a completely new experience.”

At the same time, Organigram is also actively seeking a partner with proven experience within the beverage market to take advantage of the liquid formulation it has developed.

On July 10, Organigram announced a collaboration with Lift & Co. Corp. (TSX.V: LIFT) (OTCQB: LFCOF), supporting the launch of Canada’s first branded cannabis educational program (

The program, developed in partnership with MADD Canada, aims to promote the responsible sale of cannabis and will be available via the Lift & Co. CannSell retail training program. Currently, CannSell is the only mandatory, provincially approved cannabis training program for all Ontario retail workers. Organigram is the first licensed cannabis producer in Canada to partner up with Lift & Co. for the purpose of educational content creation.

The rollout of the branded Organigram module of the program started in June 2019. The module will deliver digital training on Organigram’s three-tiered growing methodology, as well as best practices.

“This module will allow Organigram to connect directly with budtenders at any time and educate retail staff about their product attributes, best practices and stay top-of-mind with budtenders – the only people in the value chain speaking directly with consumers,” Lift & Co CEO Matei Olaru added.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit

MissionIR (MIR)
Atlanta, Georgia
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published:

This entry was posted in Organigram Holdings Inc. OGI. Bookmark the permalink.

Comments are closed.